USPTO serial 97901450
Serial No. 97901450
Reviewed by CopyMark Law Group
Status 731Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- RIOS, SASHA BOSHART
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with Serial No. 97901450?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Sensors for monitoring analyte levels for non-medical purposes; sensors for measuring analyte levels for non-medical purposes; sensors for monitoring analyte concentrations for non-medical purposes; sensors for determination of analyte concentrations for non-medical purposes; sensors used to measure and provide information related to analyte concentrations for non-medical purposes; sensors for gathering analyte concentration data for non-medical purposes; downloadable medical software and mobile applications for receiving, viewing, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, analyzing, logging and benchmarking analyte data, diabetes management data, diabetes management information, nutrition-related data, nutrition information, health-related data, health information, disease management data, disease management information, wellness-related data, and wellness information; downloadable software for capturing, measuring, tracking, and monitoring data for use with insulin delivery devices, insulin pens, namely, insulin injectors, and insulin pen caps to provide predictions and recommendations based on analyte levels for insulin dosage and medicament delivery in the field of diabetes management; downloadable Software as a Medical Device (SaMD) for managing prediabetes and diabetes by monitoring biological analytes; downloadable Software as a Medical Device (SaMD) for managing diabetes by monitoring glucose, ketone, and lactate levels; downloadable Software as a Medical Device (SaMD) for managing insulin dosage as part of diabetes management; downloadable mobile applications for capturing, measuring, tracking, and monitoring data for use with insulin delivery devices, insulin pens, namely, insulin injectors, and insulin pen caps to provide predictions and recommendations based on analyte levels for insulin dosage and medicament delivery in the field of diabetes management; downloadable software for receiving, viewing, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, analyzing, logging and benchmarking analyte data, diabetes management data, diabetes management information, nutrition-related data, nutrition information, health-related data, health information, disease management data, disease management information, wellness-related data, and wellness information in the field of medical diagnostics; downloadable mobile applications for receiving, viewing, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, analyzing, logging and benchmarking analyte data, diabetes management data, diabetes management information, nutrition-related data, nutrition information, health-related data, health information, disease management data, disease management information, wellness-related data, and wellness information in the field of medical diagnostics; downloadable software for managing health data; downloadable mobile applications for managing health, wellness, diabetes, and nutrition data; downloadable software for managing health, wellness, diabetes, and nutrition data; downloadable software for receiving, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, and analyzing analyte data; downloadable mobile applications for receiving, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, and analyzing analyte data; downloadable medical software for managing disease; downloadable mobile applications for managing disease; downloadable software for facilitating communication and collaboration between clinicians, caregivers, and patients; downloadable software for enabling users to receive personalized recommendations related to health, wellness, diabetes management, and nutrition; downloadable mobile applications for enabling users to receive personalized recommendations related to health, wellness, diabetes management, and nutrition; downloadable software for providing education in the fields of health, wellness, diabetes management, and nutrition; downloadable mobile applications for providing education in the fields of health, wellness, diabetes management, and nutrition; downloadable software to facilitate social networking in the fields of health, wellness, diabetes management, and nutrition; downloadable mobile applications to facilitate social networking in the fields of health, wellness, diabetes management, and nutrition; downloadable software to facilitate support and sharing of information the fields of health, wellness, diabetes management, and nutrition; downloadable mobile applications to facilitate support and sharing of information in the fields of health, wellness, diabetes management, and nutrition; downloadable software development kits (SDK) for receiving, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, and analyzing analyte data; downloadable application programming interface (API) software for receiving, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, and analyzing analyte data; downloadable software development kits (SDK) in the fields of health, wellness, diabetes management, and nutrition; downloadable application programming interface (API) software in the fields of health, wellness, diabetes management, and nutrition; downloadable software and mobile applications for use with analyte monitoring instruments | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 6, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 5, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 5, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 5, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 12, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 11, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 11, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 11, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 12, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 17, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 17, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 11, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 15, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 15, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 15, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 15, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 15, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 15, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 15, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 15, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 9, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jan 9, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Oct 16, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 16, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 16, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 26, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 26, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 26, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 15, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Apr 15, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jan 26, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 26, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 26, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 19, 2023 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 18, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 25, 2023 | NWAP | NEW APPLICATION ENTERED | — |